Skip to main content

Animations

MJFF Publications

2271 - 2280 of 9104 Results
Title
Year
  • Year
  • 2021
  • 2025
  • 2023
  • 2025
  • 2023
  • 2018
  • 2025
  • 2020
  • 2019
  • 2020
  • Summary Details
    OPEN
    Title: LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1080/15548627.2021.1967615
    Citation Count: 71
  • Summary Details
    OPEN
    Title: Impact of Y chromosome loss on the risk of Parkinson's disease and progression
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105769
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Statin Use and Incidence of Parkinson's Disease in Women from the French E3N Cohort Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29349
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Bioenergetic and protein processing imbalances in iPSC-dopamine neurons from individuals with idiopathic Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2025.107222
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Longitudinal hippocampal subfields, CSF biomarkers, and cognition in patients with Parkinson disease
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2023.100199
    Citation Count: 6
  • Summary Details
    OPEN
    Title: The vermiform appendix impacts the risk of developing Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aar5280
    Citation Count: 276
  • Summary Details
    OPEN
    Title: Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional study
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105567
    Citation Count: 16
  • Summary Details
    OPEN
    Title: An Increased Burden of Highly Active Retrotransposition Competent L1s Is Associated with Parkinson’s Disease Risk and Progression in the PPMI Cohort
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms21186562
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Data-Driven Subtyping of Parkinson’s Disease Using Longitudinal Clinical Records: A Cohort Study
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-37545-z
    Citation Count: 147
  • Summary Details
    OPEN
    Title: Does Serum Urate Change as Parkinson’s Disease Progresses?
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3233/jpd-202064
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.